215 related articles for article (PubMed ID: 26732302)
1. Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis.
Schneider N; Fisher C; Thway K
Ann Diagn Pathol; 2016 Feb; 20():52-8. PubMed ID: 26732302
[TBL] [Abstract][Full Text] [Related]
2. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.
Antonescu CR; Sung YS; Chen CL; Zhang L; Chen HW; Singer S; Agaram NP; Sboner A; Fletcher CD
Genes Chromosomes Cancer; 2014 Feb; 53(2):183-93. PubMed ID: 24285434
[TBL] [Abstract][Full Text] [Related]
3. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions.
Linos K; Kerr DA; Baker M; Wong S; Henderson E; Sumegi J; Bridge JA
J Cutan Pathol; 2020 Oct; 47(10):934-945. PubMed ID: 32352579
[TBL] [Abstract][Full Text] [Related]
4. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
[TBL] [Abstract][Full Text] [Related]
5. Novel recurrent PHF1-TFE3 fusions in ossifying fibromyxoid tumors.
Suurmeijer AJH; Song W; Sung YS; Zhang L; Swanson D; Fletcher CDM; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2019 Sep; 58(9):643-649. PubMed ID: 30920708
[TBL] [Abstract][Full Text] [Related]
6. A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review.
Zou C; Ru GQ; Zhao M
Exp Mol Pathol; 2021 Dec; 123():104686. PubMed ID: 34560087
[TBL] [Abstract][Full Text] [Related]
7. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant.
Graham RP; Weiss SW; Sukov WR; Goldblum JR; Billings SD; Dotlic S; Folpe AL
Am J Surg Pathol; 2013 Nov; 37(11):1751-5. PubMed ID: 23887158
[TBL] [Abstract][Full Text] [Related]
8. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells.
Hofvander J; Jo VY; Fletcher CDM; Puls F; Flucke U; Nilsson J; Magnusson L; Mertens F
Mod Pathol; 2020 Jul; 33(7):1331-1340. PubMed ID: 31932680
[TBL] [Abstract][Full Text] [Related]
9. Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors.
Atanaskova Mesinkovska N; Buehler D; McClain CM; Rubin BP; Goldblum JR; Billings SD
J Cutan Pathol; 2015 Sep; 42(9):622-31. PubMed ID: 25950586
[TBL] [Abstract][Full Text] [Related]
10. Novel MEAF6-SUZ12 fusion in ossifying fibromyxoid tumor with unusual features.
Killian K; Leckey BD; Naous R; McGough RL; Surrey LF; John I
Genes Chromosomes Cancer; 2021 Sep; 60(9):631-634. PubMed ID: 33840146
[TBL] [Abstract][Full Text] [Related]
11. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I
Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026
[TBL] [Abstract][Full Text] [Related]
12. Pediatric low-grade fibromyxoid sarcoma mimicking ossifying fibromyxoid tumor: adding to the diagnostic spectrum of soft tissue tumors with a bony shell.
Thway K; Chisholm J; Hayes A; Swansbury J; Fisher C
Hum Pathol; 2015 Mar; 46(3):461-6. PubMed ID: 25532939
[TBL] [Abstract][Full Text] [Related]
13. Ossifying fibromyxoid tumor: Fine-needle aspiration cytology findings of a rare soft tissue neoplasm.
Kumari N; Anthony ML; Durgapal P; Joshi PP; Rajput D; Singh A
Diagn Cytopathol; 2020 Apr; 48(4):396-400. PubMed ID: 31925994
[TBL] [Abstract][Full Text] [Related]
14. Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.
Endo M; Kohashi K; Yamamoto H; Ishii T; Yoshida T; Matsunobu T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Nov; 44(11):2603-8. PubMed ID: 23806526
[TBL] [Abstract][Full Text] [Related]
15. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors.
Gebre-Medhin S; Nord KH; Möller E; Mandahl N; Magnusson L; Nilsson J; Jo VY; Vult von Steyern F; Brosjö O; Larsson O; Domanski HA; Sciot R; Debiec-Rychter M; Fletcher CD; Mertens F
Am J Pathol; 2012 Sep; 181(3):1069-77. PubMed ID: 22796436
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant ossifying fibromyxoid tumor.
Cibull TL; Billings SD
Am J Dermatopathol; 2007 Apr; 29(2):156-9. PubMed ID: 17414437
[TBL] [Abstract][Full Text] [Related]
17. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.
Sbaraglia M; Bellan E; Gambarotti M; Righi A; Zanatta L; Toffolatti L; Dei Tos AP
Pathologica; 2020 Dec; 112(4):184-190. PubMed ID: 33179613
[TBL] [Abstract][Full Text] [Related]
18. Cytologic diagnosis of ossifying fibromyxoid tumor of soft tissue: a case report.
Mohanty SK; Srinivasan R; Rajwanshi A; Vasishta RK; Vignesh PS
Diagn Cytopathol; 2004 Jan; 30(1):41-5. PubMed ID: 14696144
[TBL] [Abstract][Full Text] [Related]
19. Ossifying fibromyxoid tumor: report of a case with cytomorphologic description.
Ahmed OI; Qasem SA; Salih ZT
Diagn Cytopathol; 2015 Aug; 43(8):646-9. PubMed ID: 25914177
[TBL] [Abstract][Full Text] [Related]
20. Ossifying Fibromyxoid Tumor: A Review With Emphasis on Recent Molecular Advances and Differential Diagnosis.
Carter CS; Patel RM
Arch Pathol Lab Med; 2019 Dec; 143(12):1504-1512. PubMed ID: 31765250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
